Skip to main content

1 Result(s)

within Jeong Heon Yoon Remove this filter

and

  1. No Access

    Article

    Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

    The only current curative treatment for chronic lymphocytic leukemia (CLL) is allogenic hematopoietic stem cell transplantation. Chimeric antigen receptor treatment targeting CD19 for CLL achieved some complet...

    Damian Kovalovsky, Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon… in Leukemia (2021)